Stocktoria

MUSTANG BIO, INC. MBIO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-08-22 · LEI

MUSTANG BIO, INC. statistics & valuation

Market cap$5.3M
P / B0.6×
Return on equity-20.2%
Return on capital-25.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-52.10% -52.30% -84.20% -89.80% -61.00% -59.00% -167.50% -41952.80% -20.20% 2016201720182019202020212022202320242025
Shares outstanding
15.2M 25.2M 26.6M 39.4M 70.9M 93.6M 7.7M 172031 609696 4.9M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-46.00% -49.30% -71.70% -63.20% -54.60% -53.00% -83.90% -290.80% -169.20% -10.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.76 -$10.09 -$299.95 -$38.57 -$0.39 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-10.9%-169.2%-290.8%-83.9%-53.0%-54.6%-63.2%-71.7%-49.3%-46.0%
Return on equity-20.2%406.7%-41952.8%-167.5%-59.0%-61.0%-89.8%-84.2%-52.3%-52.1%
Current ratio2.220.680.745.2210.3310.468.126.2516.998.53

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.